NEW YORK (Reuters Health) – Very small breast tumors that generate extensive lymph node involvement may be more biologically aggressive than larger tumors with the same degree of…
Teresa L. Knight, MD, FACOG, Chief Medical Officer of the Women’s Health Specialists of Saint Louis, discusses HPV and cervical cancer. To learn more about the Women’s Health…
NEW YORK (Reuters Health) – A Scientific Statement issued by the American Heart Association notes that in the US, mean triglyceride levels have increased over the past 3…
NEW YORK (Reuters Health) – Compared with standard blood gas analysis, the Masimo Radical 7 multiwave pulse oximeter measures carboxyhemoglobin noninvasively with acceptable accuracy and can be used…
NEW YORK (Reuters Health) – For patients with advanced, untreated non-small-cell lung cancer, the American Society of Clinical Oncology recommends that the tumor be tested for genetic mutations…
NEW YORK (Reuters Health) – Removing more lymph nodes from patients with lymph node positive renal cell carcinoma meant fewer died of the disease, according to a new…
NEW YORK (Reuters Health) – Use of a point-of-care troponin T assay by paramedics before patients with suspected acute MI reach the hospital is feasible and has a…
NEW YORK (Reuters Health) – Screening pregnant women for chlamydia using urine samples is just as accurate as when cervical secretions are used, suggests a new study published…
NEW YORK (Reuter Health) – With the availability of more sensitive troponin I assays, lowering the diagnostic threshold for detection of myocardial necrosis from 0.20 to 0.05 ng/mL…
NEW YORK (Reuters Health) -– A point-of-care test for beta-hydroxybutyrate in capillary blood is more specific than a urine dipstick for ketones in identifying diabetic ketoacidosis in emergency-department…
